Cargando…

Identification of distinct phenotypes related to benralizumab responsiveness in patients with severe eosinophilic asthma

PURPOSE: To characterize the clinical phenotypes of severe eosinophilic asthma based on early responsiveness to benralizumab in terms of forced expiratory volume in 1 second (FEV(1)) improvement. PATIENTS AND METHODS: Sixty-four participants diagnosed with severe eosinophilic asthma and who had comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Hideyasu, Nakajima, Masayuki, Matsuyama, Masashi, Morishima, Yuko, Arai, Naoki, Hida, Norihito, Nakaizumi, Taisuke, Masuko, Hironori, Yatagai, Yohei, Saito, Takefumi, Hizawa, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951858/ https://www.ncbi.nlm.nih.gov/pubmed/33705484 http://dx.doi.org/10.1371/journal.pone.0248305

Ejemplares similares

Relationship between lung function and inhalation devices for LAMA/LABA therapy for chronic obstructive pulmonary disease
por: Yamada, Hideyasu, et al.
Publicado: (2017)

The search for common pathways underlying asthma and COPD
por: Kaneko, Yoshiko, et al.
Publicado: (2013)

Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
por: Yamada, Hideyasu, et al.
Publicado: (2018)

A case of a pulmonary artery sling misdiagnosed as refractory asthma for 20 years
por: Inui, Toshihide, et al.
Publicado: (2017)

The Role of NRF2 in Mycobacterial Infection
por: Matsuyama, Masashi, et al.
Publicado: (2021)

Risk factors for clinical progression in patients with pulmonary Mycobacterium avium complex disease without culture-positive sputum: a single-center, retrospective study
por: Nonaka, Mizu, et al.
Publicado: (2023)

Role of Lung Function Genes in the Development of Asthma
por: Yamada, Hideyasu, et al.
Publicado: (2016)

Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection
por: Takano, Tomotsugu, et al.
Publicado: (2021)

Rapid and remarkable effectiveness of benralizumab for treating severe bronchial asthma with intractable eosinophilic rhinosinusitis and eosinophilic otitis media: A case report
por: Shimizu, Hideyasu, et al.
Publicado: (2020)

Successful treatment of eosinophilic cystitis with benralizumab
por: Cooke, W Donald, et al.
Publicado: (2020)

Eosinophilic bronchiolitis successfully treated with benralizumab
por: Sugino, Keishi, et al.
Publicado: (2021)

Expression quantitative trait loci for ETV4 and MEOX1 are associated with adult asthma in Japanese populations
por: Yatagai, Yohei, et al.
Publicado: (2021)

Genome-Wide Association Study for Levels of Total Serum IgE Identifies HLA-C in a Japanese Population
por: Yatagai, Yohei, et al.
Publicado: (2013)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia
por: Isomoto, Kohsuke, et al.
Publicado: (2020)

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
por: Jackson, David J., et al.
Publicado: (2020)

A cis-eQTL allele regulating reduced expression of CHI3L1 is associated with late-onset adult asthma in Japanese cohorts
por: Kanazawa, Jun, et al.
Publicado: (2019)

Th17-Associated Cytokines as a Therapeutic Target for Steroid-Insensitive Asthma
por: Morishima, Yuko, et al.
Publicado: (2013)

Has2 Regulates the Development of Ovalbumin-Induced Airway Remodeling and Steroid Insensitivity in Mice
por: Sherpa, Mingma Thsering, et al.
Publicado: (2022)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
por: Tsurumaki, Hiroaki, et al.
Publicado: (2019)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
por: Noorduyn, Stephen G., et al.
Publicado: (2021)

Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis
por: Koga, Yasuhiko, et al.
Publicado: (2022)

Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
por: Gómez-Bastero Fernández, Ana, et al.
Publicado: (2022)

Treatment of Widespread Eosinophilic Cellulitis (Wells’ Syndrome) with Benralizumab
por: BLOMBERG, Maria, et al.
Publicado: (2020)

Eosinophilic annular erythema showing eosinophil cytolytic ETosis successfully treated with benralizumab
por: Masaki, Katsunori, et al.
Publicado: (2021)

Rapid effect of benralizumab in fulminant eosinophilic myocarditis in the setting of uncontrolled eosinophilic asthma
por: Goyack, Laura, et al.
Publicado: (2023)

Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
por: Martínez-Rivera, Carlos, et al.
Publicado: (2021)

Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With Benralizumab
por: Sasaki, Hisashi, et al.
Publicado: (2022)

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
por: Nanzer, Alexandra M., et al.
Publicado: (2020)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
por: Woodbury, Michael J., et al.
Publicado: (2023)

Nrf2 Regulates Granuloma Formation and Macrophage Activation during Mycobacterium avium Infection via Mediating Nramp1 and HO-1 Expressions
por: Nakajima, Masayuki, et al.
Publicado: (2021)

Negative-pressure pulmonary Hemorrhaging Due to Severe Obstructive Sleep Apnea
por: Kuramoto, Kenya, et al.
Publicado: (2021)

Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases
por: Sridhar, Sriram, et al.
Publicado: (2019)

Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma
por: Park, Hae-Sim, et al.
Publicado: (2019)

Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma
por: Chia, Yen Lin, et al.
Publicado: (2019)

Emergence of extrathoracic manifestations of eosinophilic granulomatosis with polyangiitis during benralizumab treatment
por: Lim, Andy K H, et al.
Publicado: (2021)

Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity
por: Dagher, Rania, et al.
Publicado: (2022)

Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma
por: Chan, Rory, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6rsgq5971oukeba7tjttkirp2d